initial use of combined therapy has produced encouraging results which can be expected to improve with increasing experience of postirradiation surgery. The routine used is similar to that practised at Oxford since 1939 and now adopted in many world clinics. Sincerely JOHN STALLWORTHY 21 September 1976 From Dr MLederman Chairman, Division ofRadiotherapy and Oncology, Royal Marsden Hospital, Faliham Road, London SW3 Dear Sir, Few can deny the valuable contributions made by British surgeons and radiotherapists to the treatment of cancer of the cervix. The pioneer work of the Bonney surgical school had in the same era its counterpart in the radiation techniques developed by Ralston Paterson and the Manchester school which are in world-wide use to this day. Yet in spite of the technical expertise available, it has long been apparent that the results of treatment of cancer of the cervix obtained in the United Kingdom are among the worst in the world. Possible reasons for this were discussed by Blaikley et al. (1969, Jouirnal of Obstetrics and Gynwcology of the British Commoniwealth 76, 729-740) but no valid answer was found. The fact that radiotherapy dominated treatment in this country for a generation or more was not relevant in so far as centres relying on surgical treatment provided no better results. However, in this context, the contributions to the meeting held in February 1976 make sad and disappointing reading. Whilst the title of the discussion is the treatment of Stage II cancer of the cervix no uniformity of definition is apparent. Dr Cole talks about 'Stage I1 early and advanced', Mr Feroze quotes FIGO and Dr Baker includes cases with intra-abdominal nodes, lymphographically demonstrated.
This lack of uniform classification is reflected in the treatment advocated: Dr Cole, relying on a trial completed in 1963, advocates intracavitary radium alone for early Stage I1 and shows that the addition of supplementary external radiation to this group of cases adds nothing to the survival rate and, curiously enough, that the use of megavoltage radiation gave results no better than those obtained by orthovoltage X-rays. Early Stage It cases treated without supplementary external radiotherapy gave a 63.7 % five-year survival rate whilst the advanced Stage IT, with parametrial infiltration, where external irradiation was used, gave a 52.3 % crude survival rate. Few centres having adequate facilities would agree with the policy of withholding external radiation in Stage It cases and this is indirectly conceded by Dr Cole, who state's that a clinical trial has been established to show whether increasing 'the volume irradiated by. X-rays' can improve survival rates starting with Stage III cases in the'first instance.
Mr Feroze had drawn extensively on the 15th Annual FIGO Report (1975) to stress the inferiority of the results obtained in the UK. He has also with some desperation tried to provide evidence to show the superiority in treatment of surgery and radiotherapy used in combination but finally concludes that the combined method has been shown to be 'an effective form of treatment'. Incidentally, his personal table of material from King's 'College Hospital shows the natural degree of selection of cases for surgery, namely most of the Stage IIA are surgically treated and the majority of JIB cases referred for radiotherapy.
Dr Baker's paper illustrates the value of lymphography in relation to planning radiation techniques and although this investigation is not allowed to influence staging, it merits routine use. The 72 % five-year survival rate for combined Stage hIA and B appears to depend on the use of statistical refinements spurned by Dr Cole, who relies on crude survival rates. The urgent need for uniformity in presentation of results is thuis well illustrated.
Bowel damage after radiotherapyls an unhappy topic for radiotherapists and is interestingly discussed by Mr Jackson.
The conclusions to be drawn from the meeting are that there is urgent need for both surgeon and radiotherapist, particularly the latter, to try and break out of the present impasse. Apart from the use of newer techniques, e.g. the cathetron and neutron therapy, serious consideration should be given to a trial based on the accurate reproduction of existing techniques which have proved highly successful in other countries. Yours To take first the place of surgery in. bilateral neck metastases from head and neck squamous carcinoma, I must insist that if the primary lesion can be controlled bilateral neck dissection should not necessarily be denied these patients on the grounds of a poor prognosis. Mr Stell states firmly that it is contraindicated except in patients with supraglottic tum6birs, but in my own experience a few patients with squamous cancer have certainly been salvaged in these circumstances, the primary lesion having been in anterior mouth sites or in the nasopharynx. He also quotes published work to show that the survival rate for nasopharyngeal cancer with bilateral neck nodes is in single figures (Lederman M, 1967, Journal ofLaryngology and Otology 81, 151) . Careful reading of this paper reveals a fiveyear cure rate of 2 out of 20 patients, but no details of any surgery are given and the author states that these results are obtained by radiotherapy 'almost to the total exclusion of surgery'. I am also taken to task for suggesting that surgery to include neck dissection should not be denied patients suffering from carcinoma of the maxillary antrum who develop a 'gland in the neck' if there is a reasonable expectation that the primary can also be controlled. Mr Stell again quotes figures from the Radium Department of the Royal Marsden Hospital to support his contention that surgery is probably contraindicated in these cases of 'antro-ethmoidal' carcinoma (Lederman M, 1970, Journal of Laryngology anid Otology 84, 369) stating that he also used the term 'antro-ethmoidal' carcinoma in his oral presentation. Since I was not present on that occasion I could, therefore, only base my comments on his use of the term antral carcinoma in his published paper. Study of the abovementioned reference shows results given in separate 'antrum' and 'ethmoid' groups. In the former group there were in fact a very few fiveyear survivors. No details of any surgical techniques were given, nor figures relating specifically to any operations. I submit that for those rare cases of antral carcinoma with a single high level operable neck node, there is an arguable case for attempted surgical salvage despite a poor prognosis.
With regard to 'prophylactic' neck dissection, Mr Stell states that no properly conducted clinical trial has yet shown evidence that it can increase survival time in patients with cancer of the head and neck. I do not dispute that in general this is probably correct, but my previous comments were directed to his own conclusions based on a retrospective analysis of a very small number of paired cases of cancer of the larynx and pharynx only. He also admits that it is difficult to design a suitable prospective randomized trial with adequate numbers. My use of the expression 'real value' is also taken somewhat out of context and refers to the use of elective neck dissection when combined with resection of the primary lesion, to achieve better local control of the disease with facility of resection mainly in T3 tumoursthe basis of the 'Commando' operation. Finally, a plea for correct usage of words. Surely it is time to stop using the terms 'neck glands' instead of lymph nodes, and 'prophylactic' when we mean elective. Yours faithfully H J SHAW
